We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
WorldCare Clinical Promotes Richard Walovitch, Ph.D., to President
News

WorldCare Clinical Promotes Richard Walovitch, Ph.D., to President

WorldCare Clinical Promotes Richard Walovitch, Ph.D., to President
News

WorldCare Clinical Promotes Richard Walovitch, Ph.D., to President

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "WorldCare Clinical Promotes Richard Walovitch, Ph.D., to President"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

"The promotion of Richard to president is a reflection of his many contributions to WorldCare Clinical's success in expanding the breadth and depth of our service offerings," said Managing Director Michael O'Brien. "Rick's years of experience and scientific contributions in the area of medical imaging assessment strategies and processes in clinical research have allowed our company to deliver high quality services to our clients in a timely and efficient manner. Under Rick's leadership, WCC is setting new standards of performance testing and training in the critical area of reader reliability, as well as delivering quality and efficiency improvement approaches to end point assessment committee processes."

As president, Dr. Walovitch will continue to provide medical leadership for the entire organization. Additionally he is responsible for directing the operations, regulatory, sales and marketing activities and plays a vital role in defining the strategic vision of the company.
 
Dr. Walovitch joined WCC in January 2009 as chief medical officer. He previously served as senior vice president of clinical research at Acusphere, Inc., where he was responsible for the development and implementation of worldwide clinical strategies for product opportunities in multiple therapeutic areas, including cardiology imaging, oncology, pulmonology, and analgesia. Prior to Acusphere, he served as vice president of preclinical and clinical research at Epix Medical, which included supervision of Phase I and II clinical trials for an MRI angiography agent, and held various positions as research pharmacologist and project clinician in the Imaging Agent Group at the DuPont Merck Pharmaceutical Company. He completed his postdoctoral fellowship at the National Institute on Drug Abuse's Addiction Research Center in the Neurochemistry section. Dr. Walovitch has a doctorate in pharmacology from the University of Illinois Medical Center and a bachelor's degree in biology from the University of Illinois. He is an author of more than 100 peer-reviewed publications, mostly in the field of medical imaging.
Advertisement